Abstract:Hyperhomocysteinemia (HHcy) has been shown to promote vascular inflammation and atherosclerosis, but the underlying mechanisms remain largely unknown. The NLRP3 inflammasome has been identified as the cellular machinery responsible for activation of inflammatory processes. In this study, we hypothesized that the activation of NLRP3 inflammasomes contributes to HHcy-induced inflammation and atherosclerosis. ApoE −/− mice were fed regular chow, high-fat (HF) diet, or HF plus high methionine diet to induce HHcy. To assess the role of NLRP3 inflammasomes in HHcy-aggravated atherosclerosis, NLRP3 shRNA viral suspension was injected via tail vein to knock down the NLRP3 gene. Increased plasma levels of IL-1 β and IL-18, aggravated macrophage infiltration into atherosclerotic lesions, and accelerated development of atherosclerosis were detected in HHcy mice as compared with control mice, and were associated with the activation of NLRP3 inflammasomes. Silencing the NLRP3 gene significantly suppressed NLRP3 inflammasome activation, reduced plasma levels of proinflammatory cytokines, attenuated macrophage infiltration and improved HHcy-induced atherosclerosis. We also examined the effect of homocysteine (Hcy) on NLRP3 inflammasome activation in THP-1-differentiated macrophages in the presence or absence of NLRP3 siRNA or the caspase-1 inhibitor Z-WEHD-FMK. We found that Hcy activated NLRP3 inflammasomes and promoted subsequent production of IL-1 β and IL-18 in macrophages, which were blocked by NLRP3 gene silencing or Z-WEHD-FMK. As reactive oxygen species (ROS) may have a central role in NLRP3 inflammasome activation, we next investigated whether antioxidant N -acetyl- l -cysteine (NAC) prevented Hcy-induced NLRP3 inflammasome activation in macrophages. We found Hcy-induced NLRP3 inflammasome activation was abolished by NAC. Treatment with NAC in HHcy mice also suppressed NLRP3 inflammasome activation and improved HHcy-induced atherosclerosis. These data suggest that the activation of NLRP3 inflammasomes contributes to HHcy-aggravated inflammation and atherosclerosis in apoE −/− mice. Hcy activates NLRP3 inflammasomes in ROS-dependent pathway in macrophages. These results may have implication for the treatment of HHcy-associated cardiovascular diseases.

PPARδ activation inhibits homocysteine-induced p22(phox) expression in EA.hy926 cells through reactive oxygen species/p38MAPK pathway

PKC/NADPH Oxidase Are Involved in the Protective Effect of Pioglitazone in High Homocysteine-Induced Paracrine Dyfunction in Endothelial Progenitor Cells.

Homocysteine Stimulates Nuclear Factor Κb Activity and Interleukin-6 Expression in Rat Vascular Smooth Muscle Cells

Homocysteine downregulates gene expression of heme oxygenase-1 in hepatocytes

Effect of n-3 polyunsaturated fatty acid on gene expression of the critical enzymes involved in homocysteine metabolism

Ligands of Peroxisome Proliferator-activated Receptor Inhibit Homocysteine-induced DNA Methylation of Inducible Nitric Oxide Synthase Gene

Hyperhomocysteinemia Activates the Aryl Hydrocarbon Receptor/cd36 Pathway to Promote Hepatic Steatosis in Mice

Homocysteine Triggers Inflammatory Responses in Macrophages Through Inhibiting CSE-H2S Signaling Via DNA Hypermethylation of CSE Promoter

Inhibitory effect of PPAR-gamma activator on IL-6 and mPGES protein expression in PBMC induced by homocysteine.

Nuclear Factor Erythroid 2-Related Factor 2 Activation Mediates Hyperhomocysteinemia-Associated Lipolysis Suppression in Adipocytes.

Thiol antioxidant and thiol-reducing agents attenuate 15-deoxy-delta 12,14-prostaglandin J2-induced heme oxygenase-1 expression

Homocysteine promotes hepatic steatosis by activating the adipocyte lipolysis in a HIF1α-ERO1α-dependent oxidative stress manner

HHcy Induces Pyroptosis and Atherosclerosis Via the Lipid Raft-Mediated NOX-ROS-NLRP3 Inflammasome Pathway in Apoe−/− Mice

Pioglitazone Restores the Homocysteine‑impaired Function of Endothelial Progenitor Cells Via the Inhibition of the Protein Kinase C/NADPH Oxidase Pathway.

Activation of NLRP3 Inflammasomes Contributes to Hyperhomocysteinemia-Aggravated Inflammation and Atherosclerosis in Apoe-Deficient Mice.

Homocysteine Activates B Cells Via Regulating Pkm2-Dependent Metabolic Reprogramming

PPAR-γ Activators Inhibit PBMC to Release and Express Mpges Induced by HCY

Homocysteine Promotes Intestinal Inflammation in Colitis Mice Through the PGE2/STAT3 Signaling Pathway

PPARδ Agonist Prevents Endothelial Dysfunction Via Induction of Dihydrofolate Reductase Gene and Activation of Tetrahydrobiopterin Salvage Pathway

Regulation of homocysteine homeostasis through the transcriptional coactivator PGC-1alpha.

Activation of Peroxisome Proliferator-Activated Receptor Α Ameliorates Perfluorododecanoic Acid-Induced Production of Reactive Oxygen Species in Rat Liver